Observational studyPathology oncology research : POR2021

Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.

Yinan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.